I think it is a response to the scrutiny that you are under, so it is nice to talk about that...
This is common-sense legislation that would allow Medicare to negotiate directly with drug manufacturers for lower price...
Honestly, sometimes the immense benefits of solar can seem too good to be true in some of the communities that, frankly,...
I'm very concerned about this decline in confidence we see in the public when it comes to the COVID vaccine.
That's not a good situation to be in. That's very alarming as we're trying to tackle this pandemic.
I wanted to just take a moment to address an argument that we heard articulated today by these companies, which is that ...
Trust of the vaccine will be as important, if not more so, than the safety and efficacy.
if you're fighting with the public health experts, you're politicizing this, and if you're allying yourself with them, t...
But nevertheless, I don't think it is fair to try to push the blame off particularly onto the PBMs. It is the pharmaceut...
Now what Elijah knew is that the only way to really get fair pricing was to have negotiation.
I am particularly thankful that you are holding this hearing.
They are furious about it because they say they deplore his politics, and they don't want to be associated with it.
this is precisely why we need to give the government and Medicare the power to negotiate for lower drug prices because o...
Thank you very much, Madam Chair, for calling this extremely important hearing.
In just a little example, Copaxone cost our constituents $126 a day, which is four times what it costs in Germany.
Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has spe...
We need to make sure that consumers and everyday voices are a recognized constituency group and help build our policy ar...
Your companies raised the price of Copaxone 27 different times since bringing it to market more than two decades ago.
